Search

Your search keyword '"González Neira, Anna"' showing total 710 results

Search Constraints

Start Over You searched for: Author "González Neira, Anna" Remove constraint Author: "González Neira, Anna"
710 results on '"González Neira, Anna"'

Search Results

151. Genetic predisposition to ductal carcinoma in situ of the breast

152. Common non-synonymous snps associated with breast cancer susceptibility: findings from the breast cancer association consortium

154. Inflammatory-Related Genetic Variants in Non–Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment

155. Genetic predisposition to ductal carcinoma in situ of the breast

156. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

157. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

158. Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair

159. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk

160. Exome array analysis identifies <italic>ETFB</italic> as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients.

161. Nuevo modelo animal de acromatopsia

162. New animal achromatopsia model

163. Standard Versus Continuous Administration of Capecitabine in Metastatic Breast Cancer (GEICAM/2009-05): A Randomized, Noninferiority Phase II Trial With a Pharmacogenetic Analysis

164. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium

165. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.

166. Common non-synonymous SNPs associated with breast cancer susceptibility:findings from the Breast Cancer Association Consortium

167. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk:a case-control study

168. Nuevo modelo animal de acromatopsia

169. New animal achromatopsia model

170. Genome wide association study identifies a novel putative mammographic density locus at 1q12-q21

171. Genetic Variation in the TP53 Pathway and Bladder Cancer Risk. A Comprehensive Analysis

172. Tu1938 Identification of New Genetic Variants Related to Thiopurine-Induced Myelotoxicity in Inflammatory Bowel Disease (IBD) Patients With Normal Thiopurines-Methyltransferase (TPMT): A Genome-Wide Association Study

173. Identification of genetic variants associated with capecitabine-induced hand–foot syndrome through integration of patient and cell line genomic analyses

174. Application of Multi-SNP Approaches Bayesian LASSO and AUC-RF to Detect Main Effects of Inflammatory-Gene Variants Associated with Bladder Cancer Risk

175. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2

176. Isolated populations as treasure troves in genetic epidemiology: the case of the Basques

177. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics

178. Su1752 Identification of New Genetic Variants Related to Thiopurine-Induced Myelotoxicity in Inflammatory Bowel Disease (IBD) Patients With Normal Thiopurines-Methyltransferase (TPMT): A Genome-Wide Association Study

179. Association analysis between breast cancer genetic variants and mammographic density in a large population-based study (Determinants of Density in Mammographies in Spain) identifies susceptibility loci in TOX3 gene

180. Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma

181. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

182. A Polymorphism in the Cytidine Deaminase Promoter Predicts Severe Capecitabine-Induced Hand-Foot Syndrome

183. Genetic polymorphisms among C57BL/6 mouse inbred strains

184. The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors

186. Genome-wide Linkage Scan Reveals Three Putative Breast-Cancer-Susceptibility Loci

189. The portability of tagSNPs across populations: A worldwide survey

190. Evaluating HapMap SNP data transferability in a large-scale genotyping project involving 175 cancer-associated genes

191. Genetic Variation in the TP53 Pathway and Bladder Cancer Risk. A Comprehensive Analysis.

192. Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.

193. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

194. A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer.

195. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

196. Large-scale genomic analyses link reproductive ageing to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair

197. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

198. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

199. Genome-wide association analysis identifies three new breast cancer susceptibility loci

200. BRAF V600E Detection in Liquid Biopsies from Pediatric Central Nervous System Tumors.

Catalog

Books, media, physical & digital resources